Supplementary Figure 1 from Phase I Trial of a New Schedule of Romidepsin in Patients with Advanced Cancers

Laleh Amiri-Kordestani,Victoria Luchenko,Cody J. Peer, Kambiz Ghafourian,James Reynolds, Deb Draper,Robin Frye, Sue Woo,David Venzon,John Wright,Monica Skarulis,William D. Figg,Tito Fojo,Susan E. Bates,Richard L. Piekarz

crossref（2023）

引用 0|浏览12

暂无评分

摘要

Supplementary Figure 1 - PDF file 176K, Supplementary Figure 1: Comparison of dose-normalized CMAX (A) and AUCLAST (B) for the present phase I trial versus data obtained on the phase II NCI1312 trial

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要